Bridging the Gap between Bio-Pharmaceuticals,
CROs, Clinical Investigators and Trial Participants

There is a Dutch saying ‘When the first sheep crosses the gate…’.

Pharma-giant Pfizer definitely took a large step by crossing the line from the traditional ‘site-oriented’ trials to a full internet-based trial. Pfizer got approval from the FDA to ‘duplicate’ a 2007 study on a pill for overactive bladder syndrome (OAB) using the internet for both Patient recruitment and data-collection. (more…)

Let’s face it, most clinical trials face the problem of actual patient accrual falling well below expected goals. And with the ever growing number of clinical trials (at any point in time, there are at least 40,000 trials active) and the increasing number of patient per clinical trial, this problem is not going to fade away easily. (more…)